MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dysphagia"

  • 2016 International Congress

    Blunted perception of respiratory resistive loads in Parkinson’s disease

    K.W. Hegland, M.S. Troche, M.S. Okun, A.E. Brandimore (Gainesville, FL, USA)

    Objective: To determine whether differences exist in the perception of respiratory resistive loads between people with PD and age-matched control participants (HOAs). Background: Patients with…
  • 2016 International Congress

    Vocal fold augmentation in patients with Parkinson’s disease: A case series and review of the literature

    A.A. Thekdi (Houston, TX, USA)

    Objective: To describe the successful treatment of vocal fold atrophy in 2 patients with Parkinson's disease (PD) and to review key gaps in the relevant…
  • 2016 International Congress

    Clinical features of Parkinson’s disease patients developing stridor with acute respiratory failure

    J. Tashiro, S. Hamada, H. Soma, M. Nonaka, S. Honma, K. Hamada, A. Takei, F. Moriwaka, K. Tashiro (Sapporo, Japan)

    Objective: To clarify the clinical features of Parkinson's disease patients who developed stridor with acute respiratory failure due to vocal cord paralysis or laryngeal dystonia.…
  • 2016 International Congress

    Does VIM deep brain stimulation affect swallowing?

    S. De Jesus, J. Hicks, L. Almeida, L. Shahgholi, A. Patterson, A. Bona, B. Ahmed, K. Hegland, M. Okun (Gainesville, FL, USA)

    Objective: To identify the impact of DBS on airway protection in patient's post-VIM lead implantation. Background: Deep brain stimulation (DBS) targeting the ventral intermediate nucleus…
  • 2016 International Congress

    Fiberoptic endoscopic evaluation of swallowing findings in patients with Machado-Joseph disease

    J.L. Pedroso, G.L.A. Diaféria, S.W. Park, L. Haddad, F.L.M. Haddad, O.P. Barsottini (São Paulo, Brazil)

    Objective: To describe the main findings of Fiberoptic endoscopic evaluation of swallowing (FEES) in patients with MJD. Background: Machado-Joseph disease (MJD) is a degenerative process…
  • 2016 International Congress

    Swallowing disorders characteristics and the relation to cognitive level, disease duration and disease severity in patients with Huntington’s disease

    Y. Manor, D. Shpunt, N. Avniel, S. Assa, Y. Torner, A. Gad, A. Ezra, J. Knaani, A. Socher, Y. Oestriecher-Kedem, T. Gurevich (Tel Aviv, Israel)

    Objective: To characterize the swallowing disturbances of HD patients and evaluate the relation to cognition, disease duration and severity. Background: Huntington disease (HD) is a…
  • 2016 International Congress

    Dysphagia in early stage Huntington’s disease (HD) – Pilot observations from a multimodal imaging study

    I. Trender-Gerhard, E. Michou, A. Gerhard, D. Craufurd, S. Hamdy, K. Herholz (Manchester, United Kingdom)

    Objective: To assess the central neural control of swallowing in HD patients with mild dysphagia using a multimodal imaging approach combining qualitative and quantitative swallowing…
  • 2016 International Congress

    Evaluating swallowing function in patients with Huntington disease enrolled in the first-HD study

    S.A. Frank, D.O. Claassen, S. Janicki, D. Oakes, D. Stamler, V. Sung, C. Vaughn, C.M. Testa, On behalf of First-HD HSG Investigators (Boston, MA, USA)

    Objective: The Swallowing Disturbance Questionnaire (SDQ) was administered to patients with Huntington disease (HD) as part of a randomized, controlled study of deutetrabenazine for the…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley